Image de couverture de livre

The impact of active cytomegalovirus infection on donor‐derived cell‐free DNA testing in heart transplant recipients

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Amit H. Alam, Johanna Van Zyl, Hira I. Shakoor, Dana Farsakh, Ahmad B. Abdelrehim, Neville Maliakkal, Aayla K. Jamil, Raksha Patel, Joost Felius, Staci McKean, Shelley A. Hall
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	Clinical Transplantation
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Real‐life use of letermovir prophylaxis for cytomegalovirus in heart transplant recipients
par: Grégoire Saltiel, et autres
Publié: (2024)

Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors
par: Bernard S. Kadosh, et autres
Publié: (2024)

The devil is in the details: Nuances of pre‐emptive therapy for cytomegalovirus disease prevention in high‐risk seropositive donors liver transplant recipients
par: Madeleine R. Heldman, et autres
Publié: (2024)

Postoperative cognitive dysfunction in heart transplantation recipients
par: Qian Qin, et autres
Publié: (2024)

Successful combination therapy for recurrent refractory cytomegalovirus treatment in a kidney transplant recipient
par: Jennifer E. Marvin, et autres
Publié: (2024)

Prevalence of iron deficiency and anemia in pediatric heart transplant recipients
par: David M. Newland, et autres
Publié: (2024)

Advancing cytomegalovirus prevention in solid organ transplant recipients: The promise of cell‐mediated immune assays
par: Vivek B. Beechar, et autres
Publié: (2024)

Letermovir for cytomegalovirus prophylaxis in lung transplant recipients: A promising shift toward reduced myelotoxicity
par: Muath Alsharif, et autres
Publié: (2024)

Evaluating the efficacy and safety of letermovir compared to valganciclovir for the prevention of human cytomegalovirus disease in adult lung transplant recipients
par: Sydni Martinez, et autres
Publié: (2024)

Multifocal cutaneous Mycobacterium ulcerans infection in a heart transplant recipient
par: Aadith Ashok, et autres
Publié: (2024)

Long‐term outcomes for pediatric heart transplant recipients transitioning to adult care teams
par: Elena M. Donald, et autres
Publié: (2024)

Secondary anti‐viral prophylaxis in solid organ transplant recipients for the prevention of cytomegalovirus relapse: A systematic review and meta‐analysis
par: David Moynan, et autres
Publié: (2024)

Five‐year single‐center analysis of cytomegalovirus viremia in kidney transplant recipients and possible implication for novel prophylactic therapy approaches
par: Moritz Trappe, et autres
Publié: (2024)

Malignancy following solid organ transplantation: Current techniques for determination of donor versus recipient origin
par: Rebecca Rojansky, et autres
Publié: (2024)

Impact of ventricular assist device use on pediatric heart transplant waitlist mortality: Analysis of the scientific registry of transplant recipients database
par: Arene Butto, et autres
Publié: (2024)

Cytomegalovirus viral load at initiation of pre‐emptive antiviral therapy impacts cytomegalovirus dynamics in pediatric allogeneic hematopoietic cell transplantation recipients
par: Valentina Gutierrez, et autres
Publié: (2024)

A role for extensive SARS‐CoV‐2 virological assessment of donor and recipient in lung transplantation
par: Jan Van Slambrouck, et autres
Publié: (2024)

Clinical performance of the iPREDICTLIVING tool for the prediction of the post‐transplant recipient and living donor outcomes in a European cohort
par: Manuela Almeida, et autres
Publié: (2024)

Which allogeneic hematopoietic cell transplant recipients have an increased risk for delayed‐onset clinically significant cytomegalovirus infection after letermovir prophylaxis?
par: Maria Alejandra Mendoza, et autres
Publié: (2024)

Discordance in serology for cytomegalovirus, Epstein‐Barr virus and toxoplasma among thoracic organ donors
par: Chia‐Yu Chiu, et autres
Publié: (2024)

Outcomes in solid organ transplant recipients receiving organs from a donor with Fusarium solani species complex meningitis
par: Isabel S. Griffin, et autres
Publié: (2024)

Adrenal insufficiency in pediatric kidney transplantation recipients
par: Hyunwoong Harry Chae, et autres
Publié: (2024)

Dynamics of cytomegalovirus‐specific T‐cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study
par: Samantha E. Jacobs, et autres
Publié: (2024)

Tailoring cytomegalovirus prophylaxis based on T cell immunity panel assessment in kidney transplant patients at high risk of cytomegalovirus
par: Abigail M. Servais, et autres
Publié: (2024)

Atypical pneumonia testing in transplant recipients
par: Fionna Feller, et autres
Publié: (2024)

BK polyomavirus DNAemia, allograft rejection, and de novo donor‐specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients
par: Hou‐Xuan Huang, et autres
Publié: (2024)

Evaluating threshold for donor fraction cell‐free DNA using clinically available assay for rejection in pediatric and adult heart transplantation
par: Shriprasad R. Deshpande, et autres
Publié: (2024)

Results of heart transplantation in the urgent recipient - who should be transplanted?
par: David Prieto
Publié: (2014)

Lung transplantation in HIV seropositive recipients: An analysis of the UNOS registry
par: Jack K. Donohue, et autres
Publié: (2024)

Hepatitis C viremic lung transplantation to aviremic recipients: Comprehensive outcomes and post‐transplant viremia
par: Sarah Khan, et autres
Publié: (2024)

Hepatic granulomas in a pediatric liver transplant recipient
par: Giovanni Mulé, et autres
Publié: (2024)

How to choose a best kidney for pediatric kidney transplant recipients
par: Asha Moudgil, et autres
Publié: (2024)

Tixagevimab/cilgavimab for the prevention of COVID‐19 in solid organ transplant recipients
par: Emily Eribes, et autres
Publié: (2024)

Utility of a fusion protein T‐cell co‐stimulation blocker Belatacept in heart transplant recipients: Real world experience from a high volume center
par: Daniel Oren, et autres
Publié: (2024)

Clinical outcomes of lung transplant recipients with pre‐transplant Mycobacterium avium complex infection
par: Sonya M. Kothadia, et autres
Publié: (2024)

Animal models for partial heart transplantation
par: Julia Yerger, et autres
Publié: (2024)

A practical guide to real‐world implementation of pre‐emptive therapy for Cytomegalovirus disease prevention in high‐risk seronegative liver transplant recipients with seropositive donors
par: Madeleine R. Heldman, et autres
Publié: (2024)

Sexual and reproductive health screening and counseling in adolescent and young adult transplant recipients
par: Paula Cody
Publié: (2024)

Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients
par: Christie Rampersad, et autres
Publié: (2024)

Leflunomide as adjunct therapy for BK viremia management in pediatric kidney transplant recipients
par: Alexandra Aldieri, et autres
Publié: (2024)